Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Filed Aug 27, 2019 · 10-Q · 27 days after period end · 0001697884-19-000010
| Metric | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|
| Revenue | — | $2.00K | $5.00K |
| Net Income | $762.00 | -$11.97K | -$1.17K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Jul 31, 2019 · filed Aug 27, 2019 · 27 d after period end
